Cancer / Immunology
Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial
Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...
September 21, 2023 | News
Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...
September 18, 2023 | News
Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling
The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....
September 14, 2023 | News
Lunit Study Backs AI as Effective Alternative to Single Human Reader in European Double Reading System
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in...
September 12, 2023 | News
Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer
Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced the establishment of a collaboration and exclusive...
September 11, 2023 | News
Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial
Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...
September 05, 2023 | News
Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore
Agilent Technologies Inc. (NYSE: A) recently signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institu...
September 05, 2023 | News
Thyme Care Secures $60M Series B to Scale Cancer Care Beyond the Clinic
Oncology care innovator streamlines a notoriously fragmented healthcare system, reducing gaps and barriers to care for chronically under supp...
September 04, 2023 | News
Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development
Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...
September 04, 2023 | News
HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer
The study of savolitinib is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savoli...
August 29, 2023 | News
Zhiyi Biotech Begins Phase 1 Trial of SK10 for Chemo-induced Diarrhea
SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probi...
August 28, 2023 | News
Agenus Focuses on Fast-Tracking BOT/BAL Program for Cancer
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a pioneer in immuno-oncology, today announced a strategic initiative to prioritize and focus resources t...
August 24, 2023 | News
Oracle Joins White House CancerX Initiative to Aid in the Fight Against Cancer
Oracle has been recognized as a founding member of CancerX. The public-private partnership was formed to drive innovations that can help reduce deaths...
August 23, 2023 | News
Mammotome Unveils HydroMARK™ Plus: Innovative Breast Biopsy Site Marker
"I am excited for this innovative biopsy marker to come to market," said Radiologist Dr. Evita Singh, Director of Breast Imaging at Karmanos Cancer In...
August 22, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
